These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30949842)

  • 21. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.
    Katz MHG; Ou FS; Herman JM; Ahmad SA; Wolpin B; Marsh R; Behr S; Shi Q; Chuong M; Schwartz LH; Frankel W; Collisson E; Koay EJ; Hubbard JM; Leenstra JL; Meyerhardt J; O'Reilly E;
    BMC Cancer; 2017 Jul; 17(1):505. PubMed ID: 28750659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion surgery only for highly selected patients with unresectable pancreatic cancer: a satisfactory outcome in exchange for a lower resection rate.
    Natsume S; Shimizu Y; Senda Y; Hijioka S; Matsuo K; Ito S; Komori K; Abe T; Hara K
    Surg Today; 2019 Aug; 49(8):670-677. PubMed ID: 30730003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined treatment for locally advanced pancreatic cancer.
    Das M
    Lancet Oncol; 2019 Jul; 20(7):e351. PubMed ID: 31178373
    [No Abstract]   [Full Text] [Related]  

  • 24. Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective.
    Ward EP; Evans DB; Tsai S
    J Surg Oncol; 2021 May; 123(6):1405-1413. PubMed ID: 33831252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant therapy for pancreas cancer: Global perspective and optimal care pathways in low to middle-income countries.
    Rajappa SJ; Pinninti R; Are C
    J Surg Oncol; 2021 May; 123(6):1441-1448. PubMed ID: 33831251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nowadays pancreatic cancer prognosis.
    Jiménez Gordo AM; López Gómez M
    Med Clin (Barc); 2019 May; 152(10):395-396. PubMed ID: 30718002
    [No Abstract]   [Full Text] [Related]  

  • 27. Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: report of a case.
    Turner K; Levi Sandri GB; Boucher E; Hénno S; Le Prisé E; Meunier B; Boudjema K; Sulpice L
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):e29-31. PubMed ID: 25288453
    [No Abstract]   [Full Text] [Related]  

  • 28. Application of FLEEOX Preoperative Chemotherapy via Intra-arterial and Intravenous Administration in Treatment of Unresectable Locally Advanced Gastric Cancer.
    He Q; Li Y; Ma L; Ji X; Li G
    J Gastrointest Surg; 2016 Aug; 20(8):1421-7. PubMed ID: 27114248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
    Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
    Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
    Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
    J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Satoi S; Yamaue H; Kato K; Takahashi S; Hirono S; Takeda S; Eguchi H; Sho M; Wada K; Shinchi H; Kwon AH; Hirano S; Kinoshita T; Nakao A; Nagano H; Nakajima Y; Sano K; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):590-600. PubMed ID: 23660962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer.
    Rombouts SJ; Walma MS; Vogel JA; van Rijssen LB; Wilmink JW; Mohammad NH; van Santvoort HC; Molenaar IQ; Besselink MG
    Ann Surg Oncol; 2016 Dec; 23(13):4352-4360. PubMed ID: 27370653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifocal anaplastic pancreatic carcinoma requiring neoadjuvant chemotherapy and total pancreatectomy: report of a case.
    Jones TS; Jones EL; McManus M; Shah R; Gajdos C
    JOP; 2013 May; 14(3):289-91. PubMed ID: 23669483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locally advanced pancreatic adenocarcinoma: update and progress.
    Ng J; Zhang C; Gidea-Addeo D; Saif MW
    JOP; 2012 Mar; 13(2):155-8. PubMed ID: 22406589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.
    Matsumoto I; Kamei K; Omae K; Suzuki S; Matsuoka H; Mizuno N; Ozaka M; Ueno H; Kobayashi S; Uesugi K; Kobayashi M; Todaka A; Fukutomi A
    Pancreatology; 2019 Mar; 19(2):296-301. PubMed ID: 30638853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
    Fornaro L; Leone F; Vienot A; Casadei-Gardini A; Vivaldi C; Lièvre A; Lombardi P; De Luca E; Vernerey D; Sperti E; Musettini G; Satolli MA; Edeline J; Spadi R; Neuzillet C; Falcone A; Pasquini G; Clerico M; Passardi A; Buscaglia P; Meurisse A; Aglietta M; Brac C; Vasile E; Montagnani F
    Clin Colorectal Cancer; 2019 Dec; 18(4):e394-e401. PubMed ID: 31564556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.
    Strobel O; Berens V; Hinz U; Hartwig W; Hackert T; Bergmann F; Debus J; Jäger D; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S33-42. PubMed ID: 22770956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
    Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
    Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.